Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Latest Mizuho News

See all news
Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

August 10, 2026
Are rising AI costs squeezing Shopify's margins?

Are rising AI costs squeezing Shopify's margins?

August 5, 2026
Mizuho’s Bellinger on Walmart: Gig network of delivery drivers is underappreciated

Mizuho’s Bellinger on Walmart: Gig network of delivery drivers is underappreciated

July 27, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue